Mecca María Montalto de, Bartel Laura C, Castro Carmen Rodríguez de, Castro José A
Centro de Investigaciones Toxicológicas (CEITOX-CITEFA/CONICET), Villa Martelli, Buenos Aires, Argentina.
Mem Inst Oswaldo Cruz. 2008 Sep;103(6):549-53. doi: 10.1590/s0074-02762008000600007.
Benznidazole (Bz) and Nifurtimox (Nfx) have been used to treat Chagas disease. As recent studies have de-monstrated cardiotoxic effects of Nfx, we attempted to determine whether Bz behaves similarly. Bz reached the heart tissue of male rats after intragastric administration. No cytosolic Bz nitroreductases were detected, although microsomal NADPH-dependent Bz nitroreductase activity was observed, and appeared to be mediated by P450 reductase. No ultrastructurally observable deleterious effects of Bz were detected, in contrast to the overt cardiac effects previously reported for Nfx. In conclusion, when these drugs are used in chagasic patients, Bz may pose a lesser risk to heart function than Nfx when any cardiopathy is present.
苯硝唑(Bz)和硝呋替莫(Nfx)已被用于治疗恰加斯病。由于最近的研究表明Nfx具有心脏毒性作用,我们试图确定Bz是否也有类似表现。经胃内给药后,Bz到达了雄性大鼠的心脏组织。未检测到胞质Bz硝基还原酶,尽管观察到微粒体NADPH依赖性Bz硝基还原酶活性,且似乎由P450还原酶介导。与先前报道的Nfx明显的心脏效应相反,未检测到Bz在超微结构上可观察到的有害影响。总之,当这些药物用于恰加斯病患者时,在存在任何心脏病的情况下,Bz对心脏功能造成的风险可能比Nfx小。